The new genetic technology has advanced at breakneck speed. When the first genetically modified children, the twins Lulu and Nana, were born in China in 2018, it became clear that humanity was facing possibilities that we had, previously, only been able to imagine. With the pair of genetic scissors known as CRISPR, we could potentially choose the traits of our children and avoid ageing and disease. But with that ability comes a new set of risks, forcing us to face hard ethical and societal questions. How are we supposed to handle these new tools that could end up changing what is to be human?
Torill Kornfeldt has travelled all over the world to meet the people who are driving the research forward. She has visited fertility clinics in South Korea, oncologists in China who are experimenting on sick patients, and biohackers in the US who want to make the new technology available to everyone. In The Unnatural Selection of Our Species, she examines recent developments in gene editing and what might still be waiting around the corner.
Informacja dotycząca wprowadzenia produktu do obrotu:
Ten produkt został wprowadzony na rynek przed 13 grudnia 2024 r. zgodnie z obowiązującymi wówczas przepisami (Dyrektywą o ogólnym bezpieczeństwie produktów). W związku z tym może on być nadal sprzedawany bez konieczności dostosowania do nowych wymogów wynikających z Rozporządzenia o Ogólnym Bezpieczeństwie Produktów (GPSR). Produkt zachowuje pełną legalność w obrocie, a jego jakość i bezpieczeństwo pozostają zgodne z obowiązującymi wcześniej standardami.
Information regarding product placement on the market:
This product was placed on the market before December 13, 2024, in accordance with the applicable regulations at the time (the General Product Safety Directive). As a result, it can continue to be sold without needing to meet the new requirements introduced by the General Product Safety Regulation (GPSR). The product remains fully compliant with all previously valid legal standards, ensuring its continued quality and safety.